Изучение влияния различных диетических рационов на показатели цитокинового статуса и апоптоза у больных сахарным диабетом ІІ типа

70. Плотникова О.А. Диетическая коррекция нарушений липидного обмена при метаболическом синдроме / О.А. Плотникова, Х.Х. Шарафетдинов // РМЖ. - 2007. - Т.15. - №9. - С. 697-704.

71. Подгребельный А.Н. Роль фибробластов в развитии сахарного диабета и его осложнений / А.Н. Подгребельный, О.М. Смирнова, И.И. Дедов // Проблемы эндокринологии. - 2005. - Т.51. - №2. - С.14-22.

72. Потапнев М.П. Апоптоз клеток иммунной системы и его регуляция цитокинами / М.П. Потапнев // Иммунология. - 2002. - №4. - С.237-242.

73. Потешкина Н.Г. Коррекция нарушений обмена веществ при сахарном диабете 2 типа / Н.Г. Потешкина, Е.Ю. Мирина // РМЖ. - 2010. - №9. - C. 608.

74. Роль коагуляции и воспаления в развитии диабетической нефропатии у больных сахарным диабетом 2 типа / Ю.В. Хасанова, А.А. Нелаева, А.Б. Галкина, И.В. Медведева // Сахарный диабет. - 2012. -№1. - С. 31-34.

75. Роль полиненасыщенных жирных кислот семейства щ-3 в профилактике и лечении сахарного диабета 2-го тип / Р.И. Алексеева, Х.Х. Шарафетдинов, О.А. Плотникова, В.В. Зыкина // Российский медицинский журнал. - 2009. - №5. - С. 42-46.

76. Рунихин А.Ю. Современные аспекты патогенеза и лечения сахарного диабета 2 типа / А.Ю. Рунихин, Ю.В. Новикова // РМЖ. -2007. - № 27. - C. 2060-2065.

77. Самсонов М.А. О классификации лечебных диет / М.А. Самсонов // Вопросы питания. - 2007. - №1. - Т.76. - С. 47-57.

78. Симбирцев А.С. Цитокины - новая система регуляции защитных реакций организма / А.С. Симбирцев // Цитокины и воспаление. - 2002. - №1. С. 9-17.

79. Система многоуровневой диагностики нарушений пищевого статуса “Нутритест-ИП” как важный фактор клинического обследования и мониторинга состояния здоровья человека / В.А. Тутельян, Б.С. Каганов, М.Г. Гаппаров, А.К. Батурин // РМЖ. - 2009. - №5. - С. 33-38.

80. Снигур Г.Л. Апоптоз в-инсулоцитов панкреатических островков и пути его фармакокоррекции / Г.Л. Снигур, А.А. Спасов, М.П. Воронкова // Волгоградский научно-медицинский журнал. - 2012. - №2. - С. 6-8.

81. Сосудистые осложнения у больных сахарным диабетом / Р.М. Заславская, Е.У. Тулемисов, А.В.Смирнова, Б.А. Айтмагамбетова. - М: Мед практика-М. - 2006. - 264 с.

82. Статистические данные ВОЗ. Информационный бюллетень. № 312, август 2011.

83. Строков И.А. Новые возможности лечения диабетических осложнений / И.А. Строков, А.С. Фокина // РМЖ. - 2012. - № 20. - С. 996.

84. Фармакоэкономическое моделирование отдаленных результатов лечения сахарного диабета 2 типа / Под ред. И.И. Дедова, Р.И. Ягудиной. М., 2010.

85. Фибробласты и их роль в развитии соединительной ткани / И.А. Шурыгина, М.Г. Шурыгин, Н.И. Аюшинова, О.В. Каня // Сибирский медицинский журнал. - 2012. - Т.110. - №3. - С.8-12.

86. Филиппов Ю.И. Визуализация данных самоконтроля гликемии - ключ к повышению эффективности лечения пациентов с сахарным диабетом / Ю.И. Филиппов, Л.И. Ибрагимова, А.Ю. Майоров // Consilium Medicum. -2012. - Т.14. - №12. - С. 92-98.

87. Хаитов Р.М. Иммунолология / Р.М. Хаитов, Г.А. Игнатьева, И.Г. Сидорович. - Москва, 2000. - 430 С.

88. Хаитов Р.М. Руководство по клинической иммунологии. Диагностика заболеваний иммунной системы / Р.М. Хаитов, Б.В. Пинегин, А.А. Ярилин - Москва: “ГЭОТАР-Медиа”, 2009. - 345 с.

89. Черникова Н.А. Практические аспекты рационального питания при сахарном диабете / Н.А. Черникова // РМЖ.- 2009. - №10. - С.702.

90. Шарафетдинов Х.Х. Влияние диетотерапии, содержащей специализированные пищевые смеси, на динамику клинико-метаболических показателей у пациентов сахарным диабетом 2 типа / Х.Х. Шарафетдинов, О.А. Плотникова, В.А. Мещерякова // Вопросы питания. - 2005. - №2. - С.26-32.

91. Шарафетдинов Х.Х. Диетическая коррекция метаболических нарушений при сахарном диабете 2 типа: автореф. дис. ... канд. мед. наук. - Москва. - 2000. -

92. Шарафетдинов Х.Х. Лечебное питание при сахарном диабете типа 2 / Х.Х. Шарафетдинов, О.А. Плотникова, В.А. Мещерякова // Качество жизни. Медицина. Болезни эндокринной системы. - 2006. - Т.4. - №14. - С.104-109.

93. Шарафетдинов Х.Х. Методология применения пищевых смесей, используемых в энтеральном питании, в диетотерапии пациентов сахарным диабетом 2 типа / Х.Х. Шарафетдинов, В.А. Мещерякова, О.А. Плотникова // Вопросы питания. - 2005. - Т.74. - №4. - С.17-22.

94. Шварц В.Я. Воспаление жировой ткани (часть 1). Морфологические и функциональные проявления / В.Я. Шварц // Проблемы эндокринологии. - 2009. - Т.4. - №55. - С.44-49.

95. Шварц В.Я. Воспаление жировой ткани: враг или друг? / В.Я. Шварц // Цитокины и воспаление. - 2013. - Т.12. - №1(2). - С.13-21.

96. Шварц В.Я. Жировая ткань как орган иммунной системы / В.Я. Шварц // Цитокины и воспаление. - 2009. - Т.4. - №8. - С.3-10.

97. Шварц В.Я. Жировая ткань как эндокринный орган / В.Я. Шварц // Проблемы эндокринологии. - 2009. - Т.55. - №1. - С.38-44.

98. Шовдра О.Л. Роль цитокинов и аутоантител к ним в патогенезе развития ретинопатии у больных сахарным диабетом 2 типа / О.Л. Шовдра, Н.Н. Цыбиков // Дальневосточный медицинский журнал. - 2010. - №2. - С.83-85.

99. Щварц В.Я. Воспаление жировой ткани. Часть 2. Патогенетическая роль при сахарном диабете 2-го типа / В.Я. Шварц // Проблемы эндокринологии. - 2009. - Т.55. - №5. - С. 43-48.

100. Щварц В.Я. Воспаление жировой ткани. Часть 3. Патогенетическая роль в развитии атероросклероза / В.Я. Шварц // Проблемы эндокринологии. - 2009. - Т.55. -№6. - С. 40-45.

101. Щварц В.Я. Значение постпрандиальной гипергликемии в развитии сердечно-сосудистых заболеваний при сахарном диабете 2-го типа / В.Я. Шварц // Клиническая медицина. - 2009. - №11. - С.17-24.

102. Эндокринология. Национальное руководство / Под ред. И.И. Дедов и др. - М. ГЭОТАР-М: - 2008. - 1064 с.

103. Эпидемиология сахарного диабета и прогноз его распространенности в Российской Федерации. / Ю.И. Сунцов, Л.Л. Болотская, О.В. Маслова, И.В. Казаков // Сахарный диабет. - 2011. - №1. - С. 15-18.

104. A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes / C.J. Alish, W.T. Garvey, K.C. Maki, G.S. Sacks, et al. // Diabetes Technol Ther. - 2010. - V.12. - №6. - P.419-425.

105. A low-fat vegan diet elicits greater macronutrient changes, but is comparable in adherence and acceptability, compared with a more conventional diabetes diet among individuals with type 2 diabetes / N.D. Barnard, L. Gloede, J. Cohen, D.J. Jenkins, et al. // J Am Diet Assoc. - 2009. - V.109. - №2. - P.263-272.

106. A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced inflammation in white adipose tissue and liver / K. Gotoh, M. Inoue, T. Masaki, S. Chiba, et al. // Diabetes. - 2012. - V.61. - N8. - P.1994-2003.

107. A randomized clinical trial with two doses of an enteral diabetes-specific suplements in elderly patients with diabetes mellitus type 2 / D.A. De Luis, O. Izaola, B. De la Fuente, M.C. Terroba, et al. // Eur Rev Med Pharmacol Sci. - 2013. - V.17. - N12. - P.1626-30.

108. A randomized pilot trial of a moderate carbohydrate diet compared to a very low carbohydrate diet in overweight or obese individuals with type 2 diabetes mellitus or prediabetes / L.R. Saslow, S. Kim, J.J. Daubenmier, J.T. Moskowitz, et al. // PLoS One. - 2014. - V.9. - N4:e91027.

109. A systematic review of lifestyle modification and glucose intolerance in the prevention of type 2 diabetes / G.N. Thomas, C.Q. Jiang, S. Taheri, Z.H. Xiao, et al. // Curr Diabetes Rev. - 2010. - V.6. - N6. - P.378-87.

110. Abbott-97-004 Study Cooperative Group. Glycemic and lipid control in hospitalized type 2 diabetic patients: evluationof 2 enteral nutrition formulas / M. Leon Sanz, P. Garcia Luna, A. Sanz Paris, C. Gomez Candela, et al. // J Parenter Enteral Nutr. - 2005. - N29. - P.21-29.

111. Abdul-Aziz K.K. Targeting tumor necrosis factor alpha (TNF-б) in diabetic rats could approve avenues for an efficient strategy for diabetic therapy / K.K. Abdul-Aziz, M.J. Tuorkey // Diabetes Metab Syndr. - 2012. - V.6. - N2. - P.77-84.

112. Acheson K.J. Carbohydrate for weight and metabolic control: where do we stand? / K.J. Acheson // Nutrition. - 2010. - V.26. - N2. - P.141-145.

113. Acute effects of monounsaturated fatty acids with and without omega-3 fatty acids on vascular reactivity in individuals with type 2 diabetes / S.G. West, K.D. Hecker, V.A. Mustad, S. Nicholson, et al. // Diabetologia. - 2005. - V.48. - P. 113-122.

114. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease / K.H. Cheng, C.S. Chu, K.T. Lee, et al. // Int J Obes (Lond). - 2008. - N32. - P.268-274.

115. Administration of a new diabetes-specific enteral formula results in an improved 24h glucose profile in type 2 diabetic patients / A. Ceriello, M. Lansink, C.H. Rouws, van K.M. Laere, et al. // Diabetes Res Clin Pract. - 2009. - V.84. - N3. - P.259-66.

116. Advanced glycation end product precursors impair epidermal growth factor receptor signaling / M. Portero-Otнn, R. Pamplona, M.J. Bellmunt, M.C. Ruiz, et al. // Diabetes. - 2002. - V.51. - N5. - P.1535-1542.

117. Ajala O. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes / O. Ajala, P. English, J. Pinkney // Am J Clin Nutr. - 2013. -V.97. - N3. - P.505-516.

118. American Diabetes Association. Nutrition recommendations and interventions for diabetes // Diabetes Care. - 2010. - N30. - P.48-65.

119. American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors;American Society for Parenteral and Enteral Nutrition. A.S.P.E.N. clinical guidelines: nutrition support of adult patients with hyperglycemia / M.M. McMahon, E. Nystrom, C. Braunschweig, J. Miles, et al. // J Parenter Enteral Nutr. - 2013. - V.37. - N1. - P.23-36.

120. Ashkenazi A. Death receptors: signaling and modulation / A. Ashkenazi, V. Dixit // Science. - 2008. - V.281. - P.1305-1308.

121. Association between carbohydrate quality and inflammatory markers: systematic review of observational and interventional studies / A.E. Buyken, J. Goletzke, G. Joslowski, A. Felbick, et al. // Am J Clin Nutr. - 2014. - V.99. - N4. - P.813-33.

122. Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex-related analysis / P. Di Bonito, E. Sanguigno, T. Di Fraia, C. Forziato, et al. // Metabolism. - 2009. - V.58. - N3. - P.368-72.

123. Association of high carbohydrate versus high fat diet with glycated hemoglobin in high calorie consuming type 2 diabetics / Z. Shadman, M. Khoshniat, N. Poorsoltan, M. Akhoundan, et al. // J Diabetes Metab Disord. - 2013. - N12. - P.27.

124. Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes / S.K. Paine, A. Basu, L.K. Mondal, A. Sen, et al. // Mol Vis. - 2012. - V.18. - P.2749-57.

125. Associations of small dense low-density lipoprotein and adiponectin with complications of type 2 diabetes / A. Esteghamati, S. Asnafi, M. Eslamian, S. Noshad, et al. // Endocr Res. - 2014. - P.1-6.

126. Astrup A. Atkins and other low-carbohydrate diets: hoax or an effective tool for weight loss? / A. Astrup, T. Meinert Larsen, A. Harper // Lancet. - 2004. - V.364 - N9437 - P.897-899.

127. Bakhai A. Adipokines--targeting a root cause of cardiometabolic risk / A. Bakhai // QJM. - 2008. - V.101. - N10. - P.767-76.

128. Balistreri C.R. The role of adipose tissue and adipokines in obesity-related inflammatory diseases / C.R. Balistreri, C. Caruso, G. Candore // Mediators Inflamm. - 2010: www.hindawi.com/journals/mi/2010/802078/.

129. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity / Y. Miyashita, N. Koide, M. Ohtsuka, H. Ozaki, et al. // Diabetes Res Clin Pract. - 2004. - V.65. - N3. - P.235-41.

130. Beneficial effects of a diabetes specific formula on insulin sensitivity and free fatty acid in patients with type 2 diabetes mellitus / Y.X. Li, J.B. Zeng, K. Yu, Q. Sun, et al. // ChinMedJ. - 2008. - V.121. - N8. - P.691-5.

131. Bergmann K. Diabetes as a complication of adipose tissue dysfunction. Is there a role for potential new biomarkers? / K. Bergmann, G. Sypniewska // Clin Chem Lab Med. - 2013. - V.51. - N1. - P.177-185.

132. Black P.H. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II / P.H. Black // Med Hypotheses. - 2006. - V.67. - N4. - P.879-891.

133. Blood glucose and insulin responses to two hypocaloric enteral formulas in patients with diabetes mellitus type 2 / D.A. De Luis, O. Izaola, B. De la Fuente, K. Araъjo // Nutr Hosp. - 2013. - V.28. - N3. - P.600-96.

134. Bцni-Schnetzler M. How biologics targeting the IL-1 system are being considered for the treatment of type 2 diabetes / M. Bцni-Schnetzler, M.Y. Donath // Br J Clin Pharmacol. - 2013. - V.76. - N2. - P.263-268.

135. Brown S.B. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes / S.B. Brown, J. Savil // J Immunol. - 2009. - V.162. - P.480-485.

136. Brownlee M. Biochemistry and molecular cell biology of diabetic complications / M. Brownlee // Nature. - 2001. -V.73/4J4. - P.873-20.

137. Carbohydrate-restricted diets high in either monounsaturated fat or protein are equally effective at promoting fat loss and improving blood lipids / N.D. Luscombe-Marsh, M. Noakes, G.A. Wittert, J.B. Keogh, et al. // Am J Clin Nutr. - 2005. - V.81. - N4. - P.762-72.

138. Caspase-9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and function / M.J. White, S.M. Schoenwaelder, E.C. Josefsson, K.E. Jarman, et al. // Blood. - 2012. - V.119. - N18. - P.4283-90.

139. Castaсeda-Gonzбlez L.M. Effects of low carbohydrate diets on weight and glycemic control among type 2 diabetesindividuals: a systemic review of RCT greater than 12 weeks / L.M. Castaсeda-Gonzбlez, G.M. Bacardн, C.A. Jimйnez // Nutr Hosp. - 2011. - V.26. - N6. - P.1270-6.

140. Cellular hypoxia and adipose tissue dysfunction in obesity / I.S. Wood, de F.P. Heredia, B. Wang, P. Trayhurn // Proc Nutr Soc. - 2009. - V.68. - N4. - P.370-7.

141. Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes / N. Jeyaratnaganthan, K. Hшjlund, J.P. Kroustrup, J.F. Larsen, et al. // Growth Horm IGF Res. - 2010. - V.20. - N3. - P.185-91.

142. Circulating levels of TNF-б are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis Study / N.C. Olson, P.W. Callas, A.J. Hanley, A. Festa, et al. // J Clin Endocrinol Metab. - 2012. - V.97. - N3. - P.1032-40.

143. Colagiuri S. Diabesity: therapeutic options / S. Colagiuri // Diabetes Obes Metab. - 2010. - V.12. - N6. - P.463-473.

144. Colwell J. A. Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome / J. A. Colwell // JAMA. - 2011. - V.306. - N2. - P.215.

145. Comparison of 3 ad libitum diets for weight-loss maintenance, risk of cardiovascular disease, and diabetes: a 6-mo randomized, controlled trial / A. Due, T.M. Larsen, H. Mu, K. Hermansen, et al. // Am J Clin Nutr. - 2008. - V.88. - N5. - P.1232-41.

146. Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients / A. Mesejo, J.A. Acosta, C. Ortega, J. Vila, et al. // Clin Nutr. - 2003. - V.22. - N3. - P.295-305.

147. Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states / L. Berglund, M. Lefevre, H.N. Ginsberg, P.M. Kris-Etherton, et al. // Am J Clin Nutr. - 2007. - N 86. - P.1611-1620.

148. Comparison of the effects on insulin resistance and glucose tolerance of 6-mo high-monounsaturated-fat, low-fat, and control diets / A. Due, T.M. Larsen, K. Hermansen, S. Stender, et al. // Am J Clin Nutr. - 2008. - V.87. - N4. - P.855-62.

149. Coppack S.W. Pro-inflammatory cytokines and adipose tissue / S.W. Coppack // Proc Nutr Soc. - 2001. - V.60. - N3. - P.349-56.

150. De Heredia F.P. Obesity, inflammation and the immune system / F.P. De Heredia, S. Gуmez-Martнnez, A. Marcos // Proc Nutr Soc. - 2012. - V.71. - N2. - P.332-8.

151. Decreased production of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications / J.J. Corrales, M. Almeida, R.M. Burgo, et al. // J Diabetes Complications. - 2007. - N 21(1). - Р.41-49.

152. Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice / S. Wueest, R.A. Rapold, D.M. Schumann, J.M. Rytka, et al. // J Clin Invest. - 2010. - V.120. - N1. - P.191-202.

153. Dietary carbohydrates and intestinal lipoprotein production / C. Morgantini, C. Xiao, S. Dash, G.F. Lewis // Curr Opin Clin Nutr Metab Care. - 2014. 17(4). - P. 355-9.

154. Dietary fat modifies the postprandial inflammatory state in subjects with metabolic syndrome: the LIPGENE study / C. Cruz-Teno, P. Pйrez-Martнnez, J. Delgado-Lista, E.M. Yubero-Serrano, et al. // Mol Nutr Food Res. - 2012. - V.56. - N6. - P.854-65.

155. Dinarello C.A. Role of IL-1beta in type 2 diabetes / C.A. Dinarello, M.Y. Donath, T. Mandrup-Poulsen // Curr Opin Endocrinol Diabetes Obes. - 2010. - V.17. - N4. - P.314-21.

156. Dulloo A.G. Body composition, inflammation and thermogenesis in pathways to obesity and the metabolic syndrome: an overview / A.G. Dulloo, J.P. Montani // Obes Rev. - 2012. - V.13. - N2. - P.1-5.

157. Echouffo-Tcheugui J.B. Preventing diabetes mellitus in developing countries / J.B. Echouffo-Tcheugui, S. Dagogo-Jack // Nature Reviews Endocrinology. - 2012. - V.8. - P.557-562.

158. Effect of high protein vs high carbohydrate intake on insulin sensitivity, body weight, hemoglobin A1c, and blood pressure in patients with type 2 diabetes mellitus / K.R. Sargrad, C. Homko, M. Mozzoli, G. Boden // J Am Diet Assoc. - 2005. - V.105. - N4. - P.573-80.

159. Effect of TGF-в on ocular surface epithelial cells / M.J. Benito, V. Calder, R.M. Corrales, C. Garcнa-Vбzquez, et al. // Exp Eye Res. - 2013. - V.107. - P.88-100.

160. Effect of the glycemic index of the diet on weight loss, modulation of satiety, inflammation, and other metabolic risk factors: a randomized controlled trial / M. Juanola-Falgarona, J. Salas-Salvadу, N. Ibarrola-Jurado, A. Rabassa-Soler, et al. // Am J Clin Nutr. - 2014. - V.100. - N (1). - P. 27-35.

161. Effects of a diabetes-specific enteral nutrition on nutritional and immune status of diabetic, obese, and endotoxemic rats: interest of a graded arginine supply / C. Breuillard, S. Darquy, E. Curis, N. Neveux, et al. // Crit Care Med. - 2012. - V.40. - N 8. - P. 2423-30.

162. Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor-alpha in rats with sucrose-induced metabolic syndrome / A.A. Aguilera, G.H. Diaz, M.L. Barcelata, R.M. Ros // J Nutr Biochem. - 2004. - N15. - P.350-357.

163. Effects of high-monounsaturated fatty acid enteral formula versus high-carbohydrate enteralformula on plasma glucose concentration and insulin secretion in healthy individuals and diabetic patients / J. Yokoyama, Y. Someya, R. Yoshihara, H. Ishii // J Int Med Res. - 2008. - V.36. - N1. - P.137-46.

164. El-Sayed M.J.S. From obesity genetics to the future of personalized obesity therapy / M.J.S. El-Sayed, P. Froguel // Nature Reviews Endocrinology. - 2013. - V.9. - N7. - P.402-13.

165. Enerbдck S. Brown adipose tissue in humans / S. Enerbдck // Int J Obes (Lond). - 2010. - V.34. - N1. - P.43-46.

166. Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes / M. Elia, A. Ceriello, H. Laube, et al. // Diabetes Care. - 2005. - V.28. - P.2267-2279.

167. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications / M.J. Franz, J.P. Bantle, C.A. Beebe et al. // Diabetes Care. - 2002. - V.25. - P.148-198.

168. Ezaki O. The optimal dietary fat to carbohydrate ratio to prevent obesity in the Japanese population: a review of the epidemiological, physiological and molecular evidence / O. Ezaki // J Nutr Sci Vitaminol (Tokyo). - 2011. - V.57. - N6. - P.383-93.

169. Fain J.N. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review / J.N. Fain J.N. // Mediators Inflamm. - 2010:513948.

170. Fernбndez-Real J.M. Innate immunity, insulin resistance and type 2 diabetes / J.M. Fernбndez-Real, J.C. Pickup // Trends Endocrinol Metab. - 2008. - V.19. - N1. - P.10-6.

171. Ferrante A.W. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation / A.W. Ferrante // Journal of Internal Medicine. - 2007. - V.262. - N4. - P.408-414.

172. Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration / Y. Yun, J.E. Won, E. Jeon, S. Lee, et al. // Journal of Tissue Engineering. - 2010. - N 1. - 218142.

173. Fibroblasts as novel therapeutic targets in chronic inflammation / S.J. Flavell, T.Z. Hou, S. Lax, A.D. Filer, et al. // British Journal of Pharmacology. - 2008. - V.153. - N1. - P.241-246.

174. Finnish Diabetes Prevention Study Group. Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study / C. Herder, M. Peltonen, W. Koenig, K. Sьtfels, et al. // Diabetologia. - 2009. - V.52. - N3. - P.433-42.

175. FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity / C. Pop, A. Oberst, M. Drag, B.J. Van Raam, et al. // Biochem J. - 2011. - V.433. - N3. - P.447-57.

176. Franz M.J. Evidence-based diabetes nutrition therapy recommendations are effective: the key is individualization / M.J. Franz, J.L. Boucher, A.B. Evert // Diabetes Metab Syndr Obes. - 2014. - V.7. - P.65-72.

177. Frьhbeck G. The adipose tissue as a source of vasoactive factors / G. Frьhbeck // Curr Med Chem Cardiovasc Hematol Agents. - 2004. - V.2. - N3. - P.197-208.

178. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis / P. Carter, L.J. Gray, J. Troughton, K. Khunti, et al. // BMJ. - 2010. - V.341. - P.4229.

179. Galic S. Adipose tissue as an endocrine organ / S. Galic, J.S. Oakhill, G.R. Steinberg // Mol Cell Endocrinol. - 2010. - V.316. - N2. - P.129-39.

180. Georgoulis M. Mediterranean diet and diabetes: prevention and treatment / M. Georgoulis, M.D. Kontogianni, N. Yiannakouris // Nutrients. - 2014. - V.6. - N4. - P.1406-23.

181. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 / S. Wild, G. Roglic, A. Green, R. Sicree, et al. // Diabetes Care. - 2004. - V.27. - N5. - P.1047-1053.

182. Glycemic control in patientswith type 2 diabetes mellitus with type 2 diabetes mellitus with a specific disease enteral formula: stage II of a randomized, controlled multicenter trial / M. Pohl, P. Mayr, M. Mertl-Roetzer, F. Lauster, et al. // J Parenter Enteral Nutr. - 2009. - N33. - P.37-49.

183. Goldfine A.B. Therapeutic approaches to target inflammation in type 2 diabetes / A.B. Goldfine, V. Fonseca, S.E. Shoelson // Clin Chem. - 2011. - V.57. - N2. - P.162-7.

184. Green D.R. Apoptotic pathways: ten minutes to dead / D.R. Green // Cell. - 2005. - V.121. - P.671-674.

185. Gunawardana S.C. Reversal of type 1 diabetes in mice by brown adipose tissue transplant / S.C. Gunawardana, D.W. Piston // Diabetes. - 2012. - V.61. - N3. - P.674-682.

186. Heilbronn L.K. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity / L.K. Heilbronn, L.V. Campbell // Curr Pharm Des. -2008. - V.14. - N12. - P.1225-30.

187. Hemoglobin A1c as a predictor of incident diabetes / P. Cheng, B. Neugaard., P. Foulis, P.R. Conlin // Diabetes Care. - 2011. - V.34. - N3. - P.610-5.

188. High saturated-fat and low-fibre intake: a comparative analysis of nutrient intake in individuals with and without type 2 diabetes / C. Breen, M. Ryan, B. McNulty, M.J. Gibney, et al. // Nutr Diabetes. - 2014. -V.4. - N2. - P.104.

189. Hjartеker A. Obesity and diabetes epidemics: cancer repercussions / A. Hjartеker, H. Langseth, E. Weiderpass // Adv Exp Med Biol. - 2008. - N630. - P.72-93.

190. Hofman Z. The Glycemic Index of standard and diabetes-specific enteral formulas / Z. Hofman, J. De Van Drunen, H. Kuipers // Asia Pac J Clin Nutr. - 2006. - V.15. - N3. - P.412-7.

191. Hotamisligil G.S. Inflammation and metabolic disorders / G.S. Hotamisligil // Nature. - 2006. - V.444. - N7121. - P.860-867.

192. IDF Diabetes Atlas, 5th ed., 2011.

193. Implication of in?ammatory signaling pathways in obesity-induced insulin resistance / J. Tanti, F. Ceppo, J. Jager, F. Berthou // Front Endocrinol (Lausanne). - 2013. - V.3. - P.181.

194. Inflamed adipose tissue, insulin resistance and vascular injury. / C.X. Andersson, B. Gustafson, A. Hammarstedt, S. Hedjazifar, et al. // Diabetes/Metabolism Research and Reviews. - 2008. - V.24. - N8. - P.595-603.

195. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes / N. Esser, S. Legrand-Poels, J. Piette, A.J. Scheen, et al. // Diabetes Res Clin Pract. - 2014. - V.105. - N2. - P.141-50.

196. Inflammation, adiponectin, obesity and cardiovascular risk / H. Mangge, G. Almer, M. Truschnig-Wilders, A. Schmidt, et al. // Current Medicinal Chemistry. - 2010. - V.17. - N36. - P.4511-4520.

197. Inflammatory Process in Type 2 Diabetes / K. Alexandraki, C. Piperi, C. Kalofoutis, J. Singh, et al. // Annals of the New York Academy of Sciences. - 2006. - V.1084. - N1. - P.89-117.

198. Influence of fat and carbohydrate proportions on the metabolic profile in patients with type 2diabetes: a meta-analysis / S. Kodama, K. Saito, S. Tanaka, M. Maki, et al. // Diabetes Care. - 2009. - V.32. - N5. - P.959-65.

199. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome / A.H. Heald, K. Kaushal, K.W. Siddals, A.S. Rudenski, et al. // Exp Clin Endocrinol Diabetes. - 2006. - V.114. - N7. - P.371-6.

200. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes / A. Patel., S. MacMahon, J. Chalmers et al. [ADVANCE Collaborative Group] // N. Engl. J. Med. - 2008. - V.358. - P. 2560-2572.

201. Interleukin-targeted therapy for metabolic syndrome and type 2 diabetes / K. Maedler, G. Dharmadhikari, D.M. Schumann, J. Storling // Handb Exp Pharmacol. - 2011. - N203. - P.257-78.

202. International Prandial Glucose Regulation Study Group. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update / A. Ceriello, J. Davidson, M. Hanefeld, L. Leiter, et al. // Nutr Metab Cardiovasc Dis. - 2006. - N16. - P.453-456.

203. Japanese Elderly Diabetes Intervention Trial Study Group. Effects of total and green vegetable intakes on glycated hemoglobin A1c and triglycerides in elderly patients with type 2 diabetes mellitus: the Japanese Elderly Intervention Trial / K. Takahashi, C. Kamada, H. Yoshimura, R. Okumura, et al. // Geriatr Gerontol Int. - 2012. - V.12. - Suppl 1. - P.50-8.

204. Kaur B. Micronutrient status in type 2 diabetes: a review / B. Kaur, J. Henry // Adv Food Nutr Res. - 2014. - N71. - P.55-100.

205. Kazemi Arababadi M. Interleukin-4 gene polymorphisms in type 2 diabetic patients with nephropathy / M. Kazemi Arababadi // Iran J Kidney Dis. - 2010. - V.4. - N4. - P.302-6.

206. Keeley E.C. Fibrocytes: Bringing new insights into mechanisms of inflammation and fibrosis / E.C. Keeley, B. Mehrad, R.M. Strieter // The international journal of biochemistry & cell biology. - 2010. - V.42. - N4. - P. 535-542.

207. Keller U. Dietary proteins in obesity and in diabetes / U. Keller // Int J Vitam Nutr Res. - 2011. - N81 (2-3). - P.125-33.

208. Khazrai Y.M. Effect of diet on type 2 diabetes mellitus: a review / Y.M. Khazrai, G. Defeudis, P. Pozzilli // Diabetes Metab Res Rev. - 2014. - V.30. - Nl. - P.24-33.

209. King G.L.The role of inflammatory cytokines in diabetes and its complications / G.L. King // J Periodontol. - 2008. - V.79. - N8. - P.1527-34.

210. Kolluru G.K. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing / G.K. Kolluru, S.C. Bir, C.G. Kevil // Int J Vasc Med. - 2012. - 918267.

211. Kurokawa M. Caspase and kinases in a death grip / M. Kurokawa, S. Kornbluth // Cell. - 2009. - V.4. - N138 (5). - P.838-854.

212. Lam D.W. The worldwide diabetes epidemic / D.W. Lam, D. LeRoith // Curr Opin Endocrinol Diabetes Obes. - 2012. - V.19. - N2. - P.93-6.

213. Lane P.H. Streptozocin diabetes elevates all isoforms of TGF-beta in the rat kidney / P.H. Lane, D.M. Snelling, W.J. Langer // Int J Exp Diabetes Res. - 2001. - V.2. - N1. - P.55-62.

214. Le Roith D. Dyslipidemia and glucose dysregulation in overweight and obese patients / D. Le Roith // Clin Cornerstone. - 2007. - V.8. - P.38-52.

215. Long-term effect of dietary fibre intake on glycosylated haemoglobin A1c level and glycaemic control status among Chinese patients with type 2 diabetes mellitus / L. Yang., L. Shu, J. Jiang, H. Qiu, et al. // Public Health Nutr. - 2013. - P.1-7.

216. Low insulin-like growth factor-II levels predict weight gain in normal weight subjects with type 2 diabetes / A.H. Heald, L. Kдrvestedt, S.G. Anderson, J. McLaughlin, et al. // Am J Med. - 2006. - V.119. - N2. - P.167-15.

217. Low-fat versus low-carbohydrate weight reduction diets: effects on weight loss, insulin resistance, and cardiovascular risk: a randomized control trial / U. Bradley, M. Spence, C.H. Courtney, M.C. McKinley, et al. // Diabetes. - 2009. -V.58. - N12. - P.2741-48.

218. Macronutrient intake and glycemic control in a population-based sample of American Indians with diabetes: the Strong Heart Study / X. Jiaqiong, E. Sigal, M.L. Catherine, V.H. Barbara, et al. // Am. J. Clin. Nutr. - 2007. - V.86. - P.480-487.

219. Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature / M.L. Wheeler, S.A. Dunbar, L.M. Jaacks, W. Karmally, et al. // Diabetes Care. - 2012. - V.35. - N2. - P.434-45.

220. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes / E.A. Nyenwe, T.W. Jerkins, G.E. Umpierrez, A.E. Ki // Metab Clin and Experim. - 2011. - V.60. - P.1-23.

221. Mandrup-Poulsen T. AIDA study group.Interleukin-1 antagonists for diabetes / T. Mandrup-Poulsen // Expert Opin Investig Drugs. - 2013. - V.22. - N8. - P.965-79.

222. McCarthy M.I. Genome-wide association studies in type 2 diabetes / M.I. McCarthy, E. Zeggini // Curr Diab Rep. - 2009. - V.9. - N2. - P.164-71.

223. McKenzie M.D. Proapoptotic BH3-Only Protein Bid Is Essential For Death Receptor-Induced Apoptosis of Pancreatic в-Cells / MD McKenzie, EM. Carrington, T Kaufmann // Diabetes. - 2008. - V.57. - P.1284-1292.

224. McKillop A.M. Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine / A.M. McKillop, P.R. Flatt // Diabetes Care. - 2011. - V.34. - N12. - P.2624-30.

225. New percentage body fat prediction equations for Japanese females / M. Kagawa, C. Kuroiwa, K. Uenishi et al. // J Physiol Anthropol. - 2007. - V.26. - P.23-29.

226. Normal-weight obese syndrome: early inflammation? / A. De Lorenzo, V. Del Gobbo, M.G. Premrov, M. Bigioni, et al. // American Journal of Clinical Nutrition. - 2007. - V.85. - N1. - P.40-45.

227. Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance / I. Abete, A. Astrup, J.A. Martнnez, I. Thorsdottir, et al. // Nutr Rev. - 2010. - V.68. - N4. - P.214-231.

228. Olefsky J.M. Macrophages, inflammation, and insulin resistance / J.M. Olefsky, C.K. Glass // Annual Review of Physiology. - 2009. - V.72. - P.219-246.

229. Page K.A. Interventions to Preserve Beta-Cell Function in the Management and Prevention of Type 2 Diabetes / K.A. Page, T. Reisman // Curr Diab Rep. - 2013. - V.13. - N 2. - P.252-60.

230. Pancreatic islet inflammation in Type 2 diabetes: from alpha to beta cell compensation to dysfunction / J.A Ehses, H. Ellingsgaard, M. Boni-Schnetzler, M.Y. Donath // Arch Physiol Biochem. - 2009. - V.115. - P.240-247.

231. Petzke K.J. Beyond the role of dietary protein and amino acids in the prevention of diet-induced obesity / K.J. Petzke, A. Freudenberg, S. Klaus // Int J Mol Sci. - 2014. - V.15. - N1. - P.1374-91.

232. Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European prospective investigation of cancer--Norfolk prospective study / A.H. Harding, N.J. Wareham, S.A. Bingham, K. Khaw, et al. // Arch Intern Med. - 2008. - V.168. - N14. - P.1493-9.

233. Poh Z.X. A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus / Z.X. Poh, K.P. Goh // Endocr Metab Immune Disord Drug Targets. - 2009. - V.9. - N4. - P.392-8.

234. Postprandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese Type 2 diabetic patients / T.Shiraiwa, H. Kaneto, T.Miyatsuka et al. // Biochem. Biophys. Res. Commun. - 2005. - V.336. - P.339-345.

235. Pradhan A. Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders / A. Pradhan // Nutr Rev. - 2007. - V.65. - N12 (Pt 2). - P.S152-6.

236. Profile of proinflammatory cytokines in type 1 diabetes mellitus / I.H. Kyiak, N.V. Fartushok, I.I. Onyshchuk, I.M. Fedevych, et al. // Fiziol Zh. - 2012. - V.58. - N5. - P.65-9.

237. Pro-inflammatory cytokines related to severity and mortality in type 2 diabetes patients with soft tissue infection / G. Garcнa-Elorriaga, M. Padilla-Reyes, F. Cruz-Olivo, J.L. Fuentes-Allen, et al. // Rev Med Inst Mex Seguro Soc. - 2012. - V.50. - N3. - P.237-41.

238. Protein-caloric food restriction affects insulin-like growth factor system in fetal Wistar rat / M.A. Martнn, P. Serradas, S. Ramos, E. Fernбndez, et al. // Endocrinology. - 2005. - V.146. - N3. - P.1364-71.

239. Qi Q. Genetics of type 2 diabetes in European populations / Q. Qi, F.B. Hu // J Diabetes. - 2012. - V.4. - N3. - P.203-12.

240. Ramos-Nino M.E. The role of chronic inflammation in obesity-associated cancers / M.E. Ramos-Nino // ISRN Oncol. - 2013:697521.

241. Recent advances in the relationship between obesity, inflammation, and insulin resistance / J.P. Bastard, M. Maachi, C. Lagathu, et al. // European Cytokine Network. - 2006. - V.17. - N1. - P.4-12.

242. Reduction of diabetes risk in routine clinical practice: are physical activity and nutrition interventions feasible and are the outcomes from reference trials replicable? A systematic review and meta-analysis / M. Cardona-Morrell, L. Rychetnik, S.L. Morrell, P.T. Espinel, et al. // BMC Public Health. - 2010. - N10. - P.653.

243. Regulation of glucose/lipid metabolism and insulin sensitivity by interleukin-4 / Y.H. Chang, K.T. Ho, S.H. Lu, C.N. Huang, et al. // Int J Obes (Lond) . - 2012. - V.36. - N7. - P.993-8.

244. Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis / J.K. Kirk, D.E. Graves, T.E. Craven, E.W. Lipkin, et al. // J Am Diet Assoc. - 2008. - V.108. - N1. - P.91-100.

245. Role of insulin resistance and adipocytokines on serum alanine aminotransferase in obese patientswith type 2 diabetes mellitus / D.A. De Luis, R. Aller, O. Izaola, M. Gonzalez Sagrado, et al. // Eur Rev Med Pharmacol Sci. - 2013. - V.17. - N15. - P.2059-64.

246. Role of postprandial hyperglycaemia in cardiovascular disease in diabetes / S.I. Yamagishi, K. Nakamura, T. Matsui, S.I. Ueda, et al. // Int J Clin Pract. - 2007. - V.61. - P.83-87.

247. Rondinone C.M. Adipocyte-derived hormones, cytokines, and mediators / C.M. Rondinone // Endocrine. - 2006. - V.29. - N1. - P.81-90.

248. Roumen C. Lifestyle intervention for prevention of diabetes: determinants of success for future implementation / C. Roumen, E.E. Blaak, E. Corpeleijn // Nutr Rev. - 2009. - V.67. - N3. - P.132-46.

249. Ruan W. Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome? / W. Ruan, M. Lai // Acta Diabetol. - 2010. - V.47. - N1. - P.5-14.

250. Saligram S. Raised liver enzymes in newly diagnosed Type 2 diabetes are associated with weight and lipids, but not glycaemic control / S. Saligram, E.J. Williams, M.G. Masding // Indian J Endocrinol Metab. - 2012. - V.16. - N6. - P.1012-4.

251. Sattar N. Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? / N. Sattar, S.G. Wannamethee, N.G. Forouhi // Diabetologia. - 2008. - V.51. - P.926-940.

252. Schwingshackl L. Comparison of effects of long-term low-fat vs high-fat diets on blood lipid levels in overweight or obese patients: a systematic review and meta-analysis / L. Schwingshackl, G. Hoffmann // J Acad Nutr Diet. - 2013. - V.113. - N12. - P.1640-61.

253. Sell H. Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation? / H. Sell, J. Eckel // Proc Nutr Soc. - 2009. - V.68. - N4. - P.378-84.

254. Serum hyperglycemia might be not related to fat composition of diet and vegetable composition of diet might improve sugar control in taiwanese diabetic subjects / Y.C. Hou, Y.L. Chang, S.C. Kuo, C.F. Chiang, et al. // Int J Med Sci. - 2014. - V.11. - N5. - P.515-21.

255. Serum zinc and magnesium in type-2 diabetic patients / N. Masood, G.H. Baloch, R.A. Ghori, I.A. Memon, et al. // J Coll Physicians Surg Pak. - 2009. - V.19. - N8. - P.483-6.

256. Serum zinc and magnesium level in newly diagnosed type-2 diabetic subjects / S. Ferdousi, A.R. Mia, L. Mahzabeen, R.K. Nath, et al. // Mymensingh Med J. - 2013. - V.22. - N3. - P.552-6.

257. Shanthi B. Effect of iron deficiency on glycation of haemoglobin in nondiabetics / B. Shanthi, C. Revathy, A.J. Manjula Devi // J Clin Diagn Res. - 2013. - V.7. - N1. - P.15-7.

258. Sharafetdinov Kh.Kh. Methodology of use of an enteral nutrition formulas in diet therapy of patients with type 2 diabetes / Kh.Kh. Sharafetdinov, V.A. Meshcheriakova, O.A. Plotnikova // Vopr Pitan. - 2005. - V.74. - N4. - P.17-22.

259. Shaw J.E. Diabetes / J.E. Shaw, R.A. Sicree, P.Z. Zimmet // Res Clin Pract. - 2010. - V.87. - P.4-14.

260. Shoelson S.E. Inflammation and insulin resistance / S.E. Shoelson, J. Lee, A.B. Goldfine // Journal of Clinical Investigation. - 2006. - V.116. - N7. - P.1793-1801.

261. Signaling molecules involved in lipid-induced pancreatic Beta-cell dysfunction / S. Shao, Y. Yang, G. Yuan, M. Zhang, et al. // DNA Cell Biol. - 2013. - V.32. - N2. - P.41-9.

262. Slowly digestible carbohydrate sources can be used to attenuate the postprandial glycemic response to the ingestion of diabetes-specific enteral formulas / K.Van Schoonbeek, M. Lansink, K.M. Van Laere, J.M. Senden, et al. // Diabetes Educ. - 2009. - V.35. - N4. - P.631-40.

263. Speaker K.J. Interleukin-1 beta: a potential link between stress and the development of visceral obesity / K.J. Speaker, M. Fleshner // BMC Physiol. - 2012. - V.12. - P.8.

264. Steyn N.P. Conference on "Multidisciplinary approaches to nutritional problems". Symposium on "Diabetes and health". Nutrition interventions for the prevention of type 2 diabetes / N.P. Steyn, E.V. Lambert, H. Tabana // Proc Nutr Soc. - 2009. - V.68. - N1. - P.55-70.

265. Strasser A. The many roles of FAS receptor signaling in the immune system / A. Strasser, P. J Jost, S. Nagata // Immunity. - 2009. - V.30. - N2. - P. 180-192.

266. Supplementation of coenzyme Q10 and alpha-tocopherol lowers glycated hemoglobin level and lipid peroxidation in pancreas of diabetic rats / C.M. Sena, E. Nunes, A. Gomes, M.S. Santos, et al. // Nutr Res. - 2008. - V.28. - N2. - P.113-21.

267. Susan E. Apoptosis: A Review of Programmed Cell Death / E. Susan // Toxicol Pathol. - 2007. - V.35. - N4. - P.495-516.

268. Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1diabetes mellitus / J.S. Rosa, R.L. Flores, S.R. Oliver, A.M. Pontello, et al. // Pediatr Diabetes. - 2008. - V.9. - N1. - P.9-16.

269. Terry J. SmithInsulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases? / J. Terry // Pharmacol Rev. - 2010. - V.62. - N2. - P.199-236.

270. The effect of different nutritional feeds on the postprandial glucose response in healthy volunteers and patients with type II diabetes / Z. Hofman, J.D. Van Drunen, C. De Later, H. Kuipers // Eur J Clin Nutr. - 2004. - V.58. - N11. - P.1553-6.

271. The effect of enteral nutritional suspension (diabetes) (TPF-DM) on blood glucose, serum insulin and lipids in patients with type 2 diabetes / Y.X. Li, S.H. Pan, J.B. Zeng, K. Yu, et al. // Zhonghua Nei Ke Za Zhi. - 2007. - V.46. - N3. - P.193-6.

272. The effect of lipoic acid and vitamin E therapies in individuals with the metabolic syndrome / P.J. Manning, W.H. Sutherland, S.M. Williams, R.J. Walker, et al. // Nutr Metab Cardiovasc Dis. - 2013. - V.23. - N6. - P.543-9.

273. The emerging role of adipokines as mediators of inflammation and immune responses / F. Lago, C. Dieguez, J. Comez-Reino, O. Gualillo // Cytokone Growth Factor Rev. - 2008. - N18 (3-4). - P. 313-325.

274. The role of diet in the prevention of type 2 diabetes / J. Salas-Salvadу, M.Б. Martinez-Gonzбlez, M. Bullу, E. Ros // Nutr Metab Cardiovasc Dis. - 2011. - V.21. - P.32-48.

275. Tilg H. Adipocytokines: mediators linking adipose tissue, inflammation and immunity / H. Tilg, A.R. Moschen // Nature Reviews Immunology. - 2006. - V.6. - N10. - P.772-783.

276. TNF and TNF receptor expression and insulin sensitivity in human omental and subcutaneous adipose tissue--influence of BMI and adipose distribution / M. Good, F.M. Newell, L.M. Haupt, J.P. Whitehead, et al. // Diabetes and Vascular Disease Research. - 2006. - V.3. - N1.-P.26-33.

277. Townsend K. Brown adipose tissue: Recent insights into development, metabolic function and therapeutic potential / K. Townsend, Y.H. Tseng // Adipocyte. - 2012. - V.1. - N1. - P.13-24.

278. Trayhurn P. Adipokines: inflammation and the pleiotropic role of white adipose tissue / P. Trayhurn, I.S. Wood // Br J Nutr. - 2004. - V.92. - P.347-55.

279. Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity / P. Trayhurn // Physiol Rev. - 2013. - V.93. - N1. - P.1-21.

280. Trayhurn P. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? / P. Trayhurn, B. Wang, I.S. Wood // Br J Nutr. - 2008. - V.100. - N2. - P.227-35.

281. Tumor necrosis factor alpha -238G/A (rs 361525) gene polymorphism predicts progression to type-2 diabetes in an Eastern Indian population with prediabetes / D. Dutta, S. Choudhuri, S.A. Mondal, I. Maisnam, et al. // Diabetes Res Clin Pract. - 2013. - V. 99. - N 3. - P.37-41.

282. Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention / A. Badawi, K. Amira, H. Pierre, E.C. David, et al. // Diabetes Metab Syndr Obes. - 2010. - V.3. - P.173-186.

283. Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study / S. Mirza, M. Hossain, C. Mathews, P. Martinez, et al. // Cytokine. - 2012. - V.57. - N1. - P.136-42.

284. Van Haeften T.W. Insulin-like growth factors and pancreas beta cells / T.W. Van Haeften, T.B. Twickler // Eur J Clin Invest. - 2004. -V.34. - N4. - P.249-55.

285. Vaquerizo A.C. Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and EnteralNutrition (SEMICYUC-SENPE). Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and EnteralNutrition (SEMICYUC-SENPE): hyperglycemia and diabetes mellitus / A.C. Vaquerizo, C.T. Grau, D.M. Juan // Med Intensiva. - 2011. - V.35. - N1. - P.48-52.

286. Vetter M.L. Nutritional management of type 2 diabetes mellitus and obesity and pharmacologic therapies to facilitate weight loss / M.L. Vetter, A. Amaro, S. Volger // Postgrad Med. - 2014. - V.126. - N1. - P.139-52.

287. Virtue S. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome - an allostatic perspective / S. Virtue, A. Vidal-Puig // Biochim Biophys Acta. - 2010. - V.1801. - N3. - P.338-49.

288. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress. The Framingham Heart Study / J.B. Meigs, I. Lipinska, S. Kathiresan, et al. // Circulation. - 2007. - V.116. - N11. - P.1234-1241.

289. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study / K.M. Pou, J.M. Massaro, U. Hoffmann, R.S. Vasan, et al. // Circulation. - 2007. - V.116. - N11. - P.1234-41.

290. Waist circumference is an independent predictor of insulin resistance in black and white youths / S. Lee, F. Bacha, N. Gungor, S.A. Arslanian // J Pediatr. - 2006. - V.148. - N2. - P.188-94.

291. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women / K. Lee, S. Lee, Y.J. Kim, Y.J. Kim // Nutrition. - 2008. - N24 (7-8). - P.625-31.

292. Weickert M.O. Nutritional modulation of insulin resistance / M.O. Weickert // Scientifica (Cairo). - 2012:424780.

293. Weir G.C. Five stages of evolving beta-cell dysfunction during progression to diabetes / G.C Weir, S. Bonner-Weir // Diabetes. - 2004. - V.53 (Suppl. 3. - P.16-21.

294. Wellen K.E. Inflammation, stress, and diabetes / K.E. Wellen, G.S. Hotamisligil // J Clin Invest. - 2005. -V.115. - N5. - P.1111-9.

295. Wien M. A randomized controlled trial to evaluate the effect of incorporating peanuts into an American Diabetes Association meal plan on the nutrient profile of the total diet and cardiometabolic parameters of adults with type 2 diabetes / M. Wien, K. Oda, J. Sabatй // Nutr J. - 2014. - V.13. -P.10.

296. Wilding J.P. The importance of free fatty acids in the development of type 2 diabetes / J.P. Wilding // Diabet Med. - 2007. -V. 24. - P.934-945.

297. Wilson N.S. Death receptor signal transducers: nodes of coordination in immune signalimg networks / N.S. Wilson, V. Dixit, A. Ashkenazi // Nat. Immunol. - 2009. - V.10. - P.348-335.

298. Wisse B.E. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity / B.E. Wisse // J Am Soc Nephrol. - 2004. - V.15. - P.2792-80.

299. Xu F. Abnormal Cell Responses and Role of TNF-б in Impaired Diabetic Wound Healing / F. Xu, C. Zhang, D.T. Graves // Biomed Res Int. - 2013:754802.

300. Zimmet P. Preventing diabetic complications: a primary care perspective / P. Zimmet // Diabetes Res Clin Pract. - 2009. - V.84. - N2. - P.107-16.

301. б-Tocopherol status and expression of б-tocopherol transfer protein in type 2 diabetic Goto-Kakizaki rats / H. Miyazaki, K. Takitani, M. Koh, R. Takaya, et al. // J Nutr Sci Vitaminol (Tokyo). - 2013. - V.59. - N1. - P.64-8.

302. в-cell loss and в-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition / C.A. Jurgens, M.N. Toukatly, C.L. Fligner, et al. // Am J Pathol. - 2011. - V.178. - P.2632-2640.

303. 303. в-cell loss and в-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition / C.A. Jurgens, M.N. Toukatly, C.L. Fligner, et al. // Am J Pathol. - 2011. - V.178. - P.2632-2640.

Размещено на Allbest.ru

...